GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Praxsyn Corp (GREY:PXYN) » Definitions » Intrinsic Value: Projected FCF

Praxsyn (Praxsyn) Intrinsic Value: Projected FCF : $0.00 (As of May. 13, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Praxsyn Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2024-05-13), Praxsyn's Intrinsic Value: Projected FCF is $0.00. The stock price of Praxsyn is $0.0001. Therefore, Praxsyn's Price-to-Intrinsic-Value-Projected-FCF of today is 0.0.

The historical rank and industry rank for Praxsyn's Intrinsic Value: Projected FCF or its related term are showing as below:

PXYN's Price-to-Projected-FCF is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.59
* Ranked among companies with meaningful Price-to-Projected-FCF only.

Praxsyn Intrinsic Value: Projected FCF Historical Data

The historical data trend for Praxsyn's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Praxsyn Intrinsic Value: Projected FCF Chart

Praxsyn Annual Data
Trend Oct05 Oct06 Oct07 Oct08 Oct09 Dec10 Dec11 Dec12 Dec13 Dec14
Intrinsic Value: Projected FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.13 -0.20 -0.10 -0.09 -0.12

Praxsyn Quarterly Data
Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.02 -0.12 -0.02 -0.02 -0.03

Competitive Comparison of Praxsyn's Intrinsic Value: Projected FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Praxsyn's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Praxsyn's Price-to-Projected-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Praxsyn's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where Praxsyn's Price-to-Projected-FCF falls into.



Praxsyn Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)


Add all the Free Cash Flow together and divide 6 will get Praxsyn's Free Cash Flow(6 year avg) = $-5.41.

Praxsyn's Intrinsic Value: Projected FCF for today is calculated as

Intrinsic Value: Projected FCF=(Growth Multiple*Free Cash Flow (6 year avg)+Total Stockholders Equity (Sep15)*0.8)/Shares Outstanding (Diluted Average)
=(9.5203515959648*-5.40608+8.575*0.8)/1400.000
=-0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Praxsyn  (GREY:PXYN) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

Praxsyn's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=0.0001/-0.031862701682795
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Praxsyn Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of Praxsyn's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Praxsyn (Praxsyn) Business Description

Industry
Traded in Other Exchanges
N/A
Address
61 Spectrum Boulevard, Suite A, Las Vegas, NV, USA, 89101
Praxsyn Corp is a healthcare company, dedicated to providing medical practitioners with medications and services for their patients. Through its retail pharmacy facility, it formulates healthcare practitioner-prescribed medications to serve patients who experience chronic pain. It primarily focuses on non-narcotic and non-habit forming medications using therapeutic and preventative agents for pain management. In addition, the group prepares innovative products that address erectile dysfunction and metabolic issues and other ancillary products. The products of the firm are either picked up directly from pharmacy facility or shipped directly to patients. The business activities are functioned through the regions of United States.